OCULAR THERAPEUTIX, INC
OCUL
DELAYED 1 MONTH
5 insider filings · Latest: Jun 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 8:01 PM | Nadia WaheedChief Medical Officer | Sale | 14,828 | $8.27 | $122.6K | 300,079(D) | View → |
| May 26, 2026 | May 28 8:08 PM | Pravin DugelDirector, Executive Chairman, President and CEO | Sale | 21,156 | $8.20 | $173.5K | 2,597,170(D) | View → |
| May 26, 2026 | May 28 8:07 PM | Peter KaiserChief Development Officer | Sale | 2,967 | $8.20 | $24.3K | 266,141(D) | View → |
| May 26, 2026 | May 28 8:06 PM | Jeffrey S. HeierChief Scientific Officer | Sale | 3,018 | $8.20 | $24.7K | 320,350(D) | View → |
| May 26, 2026 | May 28 8:05 PM | Sanjay NayakChief Strategy Officer | Sale | 1,858 | $8.20 | $15.2K | 328,795(D) | View → |
Stock Options & Derivatives
No transactions found.